DadFinStart your free week
DadFin › Stocks › Healthcare › OMCL

Omnicell, Inc. (OMCL) stock score

Healthcare · Health Information Services · United States

$35.82 ▲ +2.84% today

99.3
Dad Score, out of 100
strong

Omnicell, Inc. (OMCL) is a Health Information Services company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 99.3 out of 100 on the Dad Score, a strong reading that places the business ahead of 99% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #8 of 974. Its strongest axes are valuation, quality and growth.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Strong
Growth
Strong
Price action
Strong
Risk
Strong
Conviction
Above average
Liquidity
Average
Macro
Average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)40.0×
P/E (forward)16.1×
Dividend yield0.00%
Return on capital0.8%
Operating margin5.9%
Revenue growth (YoY)+6.5%
FCF yield4.6%
Net debt / EBITDA-1.12×
Piotroski F-Score7 / 9
52-week change+10.1%
Market cap$1.5B
Next earningsOct 29, 2026

What subscribers see on OMCL

Start your free weekSubscriber? Open the full research →

Health Information Services peers

StockCompanyDad ScoreBandMarket cap
VEEVVeeva Systems Inc.92.5strong$44.3B
TEMTempus AI, Inc.91.3strong$13.8B
HNGEHinge Health, Inc.64.4middling$7.9B
HQYHealthEquity, Inc.98.8strong$7.4B
DOCSDoximity, Inc.95.8strong$5.0B
WAYWaystar Holding Corp.95.4strong$4.8B
HTFLHeartflow, Inc.81.7good$4.3B
PRVAPrivia Health Group, Inc.70.9good$2.6B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.